Obstructive sleep apnoea and the orexigenic pathway in type 2 diabetes.
Leow
M K S
MK
D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000503:physiopathology; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000502:physiology*; D009479:Neuropeptides / Q000502:physiology*; D000068797:Orexins; D012720:Severity of Illness Index; D020181:Sleep Apnea, Obstructive / Q000150:complications* / Q000503:physiopathology
D047908:Intracellular Signaling Peptides and Proteins; D009479:Neuropeptides; D000068797:Orexins
Eur Eat Disord Rev. 2009 Mar;17(2):120-7
19142963
Ann N Y Acad Sci. 2008;1129:287-304
18591489
Diabetes Care. 2003 Mar;26(3):702-9
12610025
Nature. 2007 Nov 15;450(7168):420-4
17943086
Diabetologia. 2010 Mar;53(3):481-8
19946661
Eur Respir J. 2003 Aug;22(2):251-7
12952256
J Clin Endocrinol Metab. 2009 Sep;94(9):3242-50
19567526
Diabetologia. 2010 Jan;53(1):10-20
19890624